Giovanni Allevi

1.5k total citations
36 papers, 1.2k citations indexed

About

Giovanni Allevi is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, Giovanni Allevi has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cancer Research, 14 papers in Oncology and 11 papers in Genetics. Recurrent topics in Giovanni Allevi's work include Breast Cancer Treatment Studies (13 papers), Estrogen and related hormone effects (10 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Giovanni Allevi is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Estrogen and related hormone effects (10 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Giovanni Allevi collaborates with scholars based in Italy, United Kingdom and Australia. Giovanni Allevi's co-authors include Alberto Bottini, Sergio Aguggini, Daniele Generali, Luigi Dogliotti, Maria Pia Brizzi, Alessandra Bersiga, Adrian L. Harris, Alfredo Berruti, Stephen B. Fox and Manuela Milani and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Giovanni Allevi

36 papers receiving 1.2k citations

Peers

Giovanni Allevi
Giovanni Allevi
Citations per year, relative to Giovanni Allevi Giovanni Allevi (= 1×) peers Sergio Aguggini

Countries citing papers authored by Giovanni Allevi

Since Specialization
Citations

This map shows the geographic impact of Giovanni Allevi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Allevi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Allevi more than expected).

Fields of papers citing papers by Giovanni Allevi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Allevi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Allevi. The network helps show where Giovanni Allevi may publish in the future.

Co-authorship network of co-authors of Giovanni Allevi

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Allevi. A scholar is included among the top collaborators of Giovanni Allevi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Allevi. Giovanni Allevi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Generali, Daniele, Silvia Paola Corona, Lajos Pusztai, et al.. (2018). Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR. Journal of Cancer Research and Clinical Oncology. 144(3). 601–606. 3 indexed citations
2.
Andreis, Daniele, Giovanni Allevi, Sergio Aguggini, et al.. (2016). Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer. The Breast. 29. 55–61. 8 indexed citations
3.
Allevi, Giovanni, et al.. (2015). Luxation of the superficial digital flexor tendon in a dog: a case report.. 29(6). 57–61. 1 indexed citations
4.
Generali, Daniele, Alfredo Berruti, Laura Zanotti, et al.. (2015). Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1  and Relation to Clinical Response. JNCI Monographs. 2015(51). 64–66. 6 indexed citations
5.
Koukourakis, Michael I., Alexandra Giatromanolaki, Alberto Bottini, et al.. (2014). Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy. British Journal of Cancer. 110(9). 2209–2216. 18 indexed citations
6.
Generali, Daniele, Francesca M. Buffa, Siddhartha Deb, et al.. (2014). COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment. British Journal of Cancer. 111(1). 46–54. 33 indexed citations
7.
Allevi, Giovanni, Carla Strina, Daniele Andreis, et al.. (2013). Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer. British Journal of Cancer. 108(8). 1587–1592. 46 indexed citations
8.
Generali, Daniele, Alfredo Berruti, Chiara Foroni, et al.. (2011). Molecular Oncology and the Neoadjuvant Setting: the Perfect Blend for Treatment Personalization and Clinical Trial Design. JNCI Monographs. 2011(43). 67–70. 5 indexed citations
9.
Generali, Daniele, Stephen B. Fox, Maria Pia Brizzi, et al.. (2010). Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients. Breast Cancer Research and Treatment. 123(3). 795–804. 12 indexed citations
10.
Generali, Daniele, Gaynor J. Bates, Maria Pia Brizzi, et al.. (2009). Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients. Clinical Cancer Research. 15(3). 1046–1051. 129 indexed citations
11.
Generali, Daniele, Andrea Dovio, Marco Tampellini, et al.. (2008). Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases. British Journal of Cancer. 98(11). 1753–1758. 14 indexed citations
12.
Generali, Daniele, Stephen B. Fox, Alfredo Berruti, et al.. (2007). Regulation of Hepatocyte Growth Factor Activator Inhibitor 2 by Hypoxia in Breast Cancer. Clinical Cancer Research. 13(2). 550–558. 12 indexed citations
13.
Dovio, Andrea, Daniele Generali, Marco Tampellini, et al.. (2007). Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis. Osteoporosis International. 19(1). 113–117. 21 indexed citations
14.
Generali, Daniele, Stephen B. Fox, Francesca M. Buffa, et al.. (2006). Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients. Annals of Oncology. 17. 103–104. 6 indexed citations
15.
Generali, Daniele, Stephen B. Fox, Alfredo Berruti, et al.. (2006). Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer. Endocrine Related Cancer. 13(3). 921–930. 66 indexed citations
16.
Berruti, Alfredo, Alberto Bottini, Giovanni Allevi, et al.. (2004). Magnetic Resonance Imaging in Comparison to Clinical Palpation in Assessing the Response of Breast Cancer to Epirubicin Primary Chemotherapy. Breast Cancer Research and Treatment. 85(3). 211–218. 30 indexed citations
17.
Bottini, Alberto, Alfredo Berruti, Maria Pia Brizzi, et al.. (2003). Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer. British Journal of Cancer. 89(6). 977–982. 35 indexed citations
18.
Bottini, Alberto, Alfredo Berruti, Alessandra Bersiga, et al.. (2002). Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer.. PubMed. 8(6). 1816–21. 41 indexed citations
19.
Berruti, Alfredo, Alberto Bottini, Maria Pia Brizzi, et al.. (2001). Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. Breast Cancer Research and Treatment. 69(2). 143–151. 47 indexed citations
20.
Bottini, Alberto, Alfredo Berruti, Alessandra Bersiga, et al.. (2001). Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer. British Journal of Cancer. 85(8). 1106–1112. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026